Covered recipient · General Payments record
EBUBEKIR SITTIK DAGLILAR
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,139.81
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $447.91 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.80 | 3 |
| Madrigal Pharmaceuticals | $114.46 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $70.36 | 2 |
| PFIZER INC. | $50.45 | 2 |
| Phathom Pharmaceuticals, Inc. | $23.13 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $21.39 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.25 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103527901 | CMS |
| ABBVIE INC. | $8.74 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103527903 | CMS |
| ABBVIE INC. | $123.81 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103527905 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $21.39 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147022756 | CMS |
| Boston Scientific Corporation | $26.75 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092575329 | CMS |
| Boston Scientific Corporation | $43.61 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092575331 | CMS |
| Madrigal Pharmaceuticals | $114.46 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144164029 | CMS |
| PFIZER INC. | $27.36 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131736712 | CMS |
| PFIZER INC. | $23.09 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131214388 | CMS |
| Phathom Pharmaceuticals, Inc. | $23.13 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151053089 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.32 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137522755 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.